For research use only. Not for therapeutic Use.
Garetosmab（Cat No.:I042093）is an investigational monoclonal antibody that targets and inhibits the growth differentiation factor 8 (GDF-8), also known as myostatin. GDF-8 plays a role in regulating muscle growth, and its inhibition can potentially promote muscle growth and improve conditions associated with muscle wasting. Garetosmab is being studied for its potential to treat disorders like Duchenne muscular dystrophy (DMD) and other conditions involving muscle loss. Clinical trials are ongoing to assess its safety, efficacy, and ability to increase muscle mass and function in affected patients, particularly in genetic muscle diseases.
| CAS Number | 2097125-54-5 |
| Purity | ≥95% |
